Dr. William Francis Morano Jr., MD

Dr. Morano practices at FWCC Precision Medicine Genomics Laboratory in Shreveport, Louisiana.

Dr. Morano's NPI, 1548609969, was assigned on June 19, 2013. Dr. Morano graduated from Drexel University College of Medicine in 2013. Dr. Morano holds Pennsylvania license MD455383.

Dr. Morano's primary practice is FWCC Precision Medicine Genomics Laboratory, at 1501 Kings Hwy, Bri F2-12/13, Shreveport, LA 71103. The practice phone is (318) 675-4327.

Dr. Morano's primary practice is FWCC Precision Medicine Genomics Laboratory in Shreveport, Louisiana. Dr. Morano is also affiliated with Lankenau Medical Center. The medical group on file is LSU Health Shreveport. Dmand AI also links Dr. Morano to 3 more hospitals, 1 group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Morano practices, 7 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Morano's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dmand AI has Dr. Morano's licenses on file in 2 states: Pennsylvania and Louisiana.

CMS data shows 21 Medicare services from Dr. Morano across 1 procedure code in 2024, for 65 Medicare patients. Medicare paid $2,909 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 65 Medicare patients who saw Dr. Morano in 2024. The largest group is 75 to 84, with 29 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Morano's median patient age at 65, with 53% women.

In 2024, Dr. Morano wrote 45 Medicare Part D claims for 29 patients. 100% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $23 in total drug cost. In 2021, CMS named 13 claims across 1 drug.

Dr. Morano accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 16 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Morano, more than 47% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 19 papers to Dr. Morano, published from 2016 to 2019. 2019 was the busiest year, with 5. The most frequent topics are Peritoneal Neoplasms, Apoptosis and Proto-Oncogene Proteins c-mdm2. Dr. Morano has published most often in Ann Clin Lab Sci. Dr. Morano's most frequent co-authors are Wilbur B. Bowne, MD, Marian Khalili, MD and Elizabeth Moran Gleeson, MD.

CMS Open Payments shows 29 general payments to Dr. Morano from 17 drug and device companies from 2017 to 2025. Education make up the largest share, 91% of the total. Intuitive Surgical, Inc. paid the most, $10,392.

Dr. Morano graduated from Drexel University College of Medicine in 2013.